Expert Review of Neurotherapeutics

News in brief
pp. 1-3(3)

Donepezil (Aricept®) for treatment of Alzheimer´s disease and other dementing conditions
pp. 5-16(12)
Author: Geldmacher, David S

Mitoxantrone (Novantrone®) in multiple sclerosis: new insights
pp. 17-26(10)
Authors: Neuhaus, Oliver; Kieseier, Bernd C; Hartung, Hans-Peter

Botulinum toxin type A (Botox®) in the treatment of migraine and other headaches
pp. 27-31(5)
Author: Troost, B Todd

Zolmitriptan (Zomig®)
pp. 33-41(9)
Authors: Rapoport, Alan M; Bigal, Marcelo E; Tepper, Stewart J; Sheftell, Fred D

Verbal memory deficit in patients with schizophrenia: an important future target for treatment
pp. 43-52(10)
Authors: Toulopoulouand, Timothea; Murray, Robin M

Pharmacologic treatment of adolescent and child schizophrenia
pp. 53-60(8)
Authors: Young, Christopher M; Findling, Robert L

Course of cognitive functioning in first episode schizophrenia spectrum disorders
pp. 61-68(8)
Authors: Townsend, Laurel A; Norman, Ross MG

Review of magnetic resonance imaging and spectroscopy studies in children with bipolar disorder
pp. 69-77(9)
Authors: Adleman, Nancy E; Barnea-Goraly, Naama; Chang, Kiki D

Insulin-like growth factor I and Alzheimer´s disease: therapeutic prospects?
pp. 79-86(8)
Authors: Carro, Eva; Torres-Aleman, Ignacio

Angiotensin and Alzheimer´s disease: therapeutic prospects
pp. 87-96(10)
Authors: Gard, Paul R; Rusted, Jennifer M

Novel ventriculo­peritoneal shunt in Alzheimer´s disease cerebrospinal fluid biomarkers
pp. 97-107(11)
Authors: Silverberg, Gerald D; Mayo, Martha; Saul, Thomas; Carvalho, Joan; McGuire, Dawn

Assessment and prediction of functional impairment in vascular dementia
pp. 109-114(6)
Authors: Boyle, Patricia A; Cahn-Weiner, Deborah

Nerve growth factor and chronic daily headache: a potential implication for therapy
pp. 115-127(13)
Authors: Sarchielli, Paola; Gallai, Virgilio

Therapy for neurocysticercosis
pp. 129-139(11)
Author: Takayanagui, Osvaldo Massaiti